Author Archives: Taylor Mercado

PMID:  Vaccine. 2019 Sep 20 ;37(40):5986-5993. Epub 2019 Aug 23. PMID: 31451326 Abstract Title:  The mad leading the blind: Perceptions of the vaccine-refusal movement among Australians who support vaccination. Abstract:  BACKGROUND: Vaccine refusal is shaped by the social ecology in which it occurs. How people who refuse vaccines are communicated to and treated may affect …

Continue reading “Subjects who supported vaccination had negative perceptions of the vaccine-refusal movement, believing the movement is dangerous and comprised of charlatans/fools who are unintelligent, selfish, hyperemotional, conspiratorial and scientifically illiterate”

PMID:  Vaccine. 2019 Sep 24 ;37(41):6093-6101. Epub 2019 Aug 27. PMID: 31471145 Abstract Title:  The cost saving opportunity of introducing a card review into measles-containing vaccination campaigns. Abstract:  Measles vaccination is a cost-effective way to prevent infection and reduce mortality and morbidity. However, in countries with fragile routine immunization infrastructure, coverage rates are still low …

Continue reading “During vaccine campaigns, children who are already immune to measles often receive an additional and unnecessary vaccine.”

PMID:  Vaccine. 2019 Sep 30 ;37(42):6201-6207. Epub 2019 Sep 5. PMID: 31495592 Abstract Title:  Phase 1 trial of a 20-valent pneumococcal conjugate vaccine in healthy adults. Abstract:  INTRODUCTION: Streptococcus pneumoniae is a leading cause of bacteremia, bacterial pneumonia, and meningitis, and is associated with substantial morbidity and mortality, particularly in those under 2 years of age …

Continue reading “72.7% of subjects experienced systemic events (fatigue, headache, chills, nausea/ vomiting, new muscle pain, aggravated muscle pain, new joint pain, and aggravated joint pain) after receiving a 20-valent pneuomococcal vaccine.”

PMID:  Vaccine. 2019 Sep 30 ;37(42):6144-6153. Epub 2019 Sep 4. PMID: 31493949 Abstract Title:  Clinical trials with GMO-containing vaccines in Europe: Status and regulatory framework. Abstract:  Recombinant technology has revolutionised the way novel vaccines are developed and manufactured. The possibility to genetically modify micro-organisms to bring immunogenic material (antigens/epitopes) to the human (or animal) immune …

Continue reading “GMO vaccines are in the pipeline.”

PMID:  J Ethnopharmacol. 2020 Jan 10 ;246:112242. Epub 2019 Sep 15. PMID: 31533077 Abstract Title:  Musa acuminata and its bioactive metabolite 5-Hydroxymethylfurfural mitigates quorum sensing (las and rhl) mediated biofilm and virulence production of nosocomial pathogen Pseudomonas aeruginosa in vitro. Abstract:  ETHNOPHARMACOLOGICAL RELEVANCE: Musa acuminata, a tropical plant belongs to the family Musaceae. The fruit …

Continue reading “Musa acuminata mitigates quorum sensing mediated biofilm and virulence production of nosocomial pathogen Pseudomonas aeruginosa.”

PMID:  Arch Physiol Biochem. 2019 Nov 5:1-13. Epub 2019 Nov 5. PMID: 31687854 Abstract Title:  Assessment of antidiabetic potential ofpeel extract and its fractions in experimental animals and characterisation of its bioactive compounds by HPTLC. Abstract:  is a rich source of nutritional food with acclaimed therapeutic uses. Banana pulp has been reported to possess antidiabetic …

Continue reading “Musa acuminata possess antidiabetic potential by reducing plasma glucose.”

PMID:  Molecules. 2019 Dec 13 ;24(24). Epub 2019 Dec 13. PMID: 31847066 Abstract Title:  NO-, IL-1β-, TNF-α-, and IL-6-Inhibiting Effects and Trypanocidal Activity of Banana () Bracts and Flowers: UPLC-HRESI-MS Detection of Phenylpropanoid Sucrose Esters. Abstract:  Banana inflorescences are a byproduct of banana cultivation consumed in various regions of Brazil as a non-conventional food. This …

Continue reading “The obtained results revealed that banana inflorescences could be used as an anti-inflammatory food ingredient to control inflammatory diseases.”

PMID:  Biomed Pharmacother. 2019 Dec ;120:109439. Epub 2019 Oct 4. PMID: 31590126 Abstract Title:  Adipose tissue as a possible therapeutic target for polyphenols: A case for Cyclopia extracts as anti-obesity nutraceuticals. Abstract:  Obesity is a significant contributor to increased morbidity and premature mortality due to increasing the risk of many chronic metabolic diseases such as …

Continue reading “The aim of this review is to assess the potential of Cyclopia extracts as an anti-obesity nutraceutical.”

PMID:  Ann N Y Acad Sci. 2020 Jan 13. Epub 2020 Jan 13. PMID: 31930541 Abstract Title:  Betulinic acid restores imatinib sensitivity in BCR-ABL1 kinase-independent, imatinib-resistant chronic myeloid leukemia by increasing HDAC3 ubiquitination and degradation. Abstract:  Although imatinib (IM) has been demonstrated to be an efficient treatment in chronic myeloid leukemia (CML), some patients still …

Continue reading “Betulinic acid restores imatinib sensitivity in BCR-ABL1 kinase-independent, imatinib-resistant chronic myeloid leukemia.”

PMID:  Biochem Biophys Res Commun. 2020 Jan 13. Epub 2020 Jan 13. PMID: 31948750 Abstract Title:  Suppression of HIF-1α accumulation by betulinic acid through proteasome activation in hypoxic cervical cancer. Abstract:  Betulinic acid (BA) exhibits various biological activities such as anti-bacterial, anti-inflammatory, anti-human papilloma virus (HPV), and anti-cancer activities. HPV infection is associated with a …

Continue reading “Suppression of HIF-1α accumulation by betulinic acid through proteasome activation in hypoxic cervical cancer.”